--Promoted within 1.5 years for exceptional performance and results delivery for multiple enterprise clients--Directed a team of solution architects and implementation managers to conduct a thorough current state analysis and future state design at a leading global biotech company, culminating in the successful development of a comprehensive AI-ready data model on Benchling for 1,300 users across multiple R&D departments--Executed a large-scale data harmonization project and established robust data governance protocols at a leading American agricultural chemical and seed company--Developed and implemented an all-encompassing solution strategy for a prominent APAC-based Contract Development & Manufacturing Organization, adeptly managing multiple external partners and incorporating GxP compliance requirements --Strategically guided the development of Benchling's product roadmap, advocating for feature enhancements tailored to the needs and priorities of Benchling’s largest customers--Developed global enterprise processes and best practices initiatives for use across Benchling’s client base

--Promoted within 1.5 years for superior performance--Executed end-to-end implementation of the Benchling platform for a diverse portfolio of clients in the biotech, pharma, and agriscience sectors, ranging from emerging startups to established enterprise companies--Managed cross-functional teams in the tailored customization of solutions, consistently meeting client-specific business needs while ensuring projects were delivered on schedule and with a high standard of quality--Conducted in-depth business analysis and solution delivery for complex and high-throughput scientific workflows, achieving up to 90% time savings and enhanced data standardization and accuracy

--Advised global emerging and established pharma clients in engagements ranging from opportunity assessment, strategic forecasting, corporate strategy, life-cycle management, and product launch strategy across a range of therapeutic areas (i.e., hematology, neurology, oncology, infectious disease)--Delivered strategic recommendations to VPs and directors of commercial strategy, medical affairs, government affairs, and other business units

--Conducted dissertation research work in Dr. Tejal Desai's laboratory--Managed multi-year projects with global teams of academic and industry scientists, clinicians, and investors --Developed expertise in pharmaceuticals, nanotechnology, and polymer chemistry--Provided technical consulting services to an early-stage company to obtain data for patent enablement--Supervised and mentored three Ph.D. students in both research activities and professional development

--Manager of life science investment fund with AUM totaling over $175,000--Performed due diligence on pharmaceutical and medtech companies and pitched best candidates to fund partners--Developed analyst training program to improve quality of partners’ investment due diligence and presentations--Designed a website to promote the fund and attract new talent from top schools and companies in the Bay Area

--Created dataset of biopharma acquisitions in the past two decades and analyzed key industry trends--Interviewed key opinion leaders, investors, and company founders--Reviewed company pitches for potential investment

--Performed due diligence on life science startups selected for potential investment by angel investors and venture capitalists in collaboration with QB3--Analyzed scientific merit, intellectual property, market attractiveness, and competitive landscape for three companies in neurology, reproductive health, and diagnostic tools

--I worked closely with Technology Licensing Officers to assist with technology assessments and marketing--Evaluated 12 early-stage technologies for commercial potential and patentability--Advised university inventors on matters related to entrepreneurship, patentability, and commercialization--Produced marketing material for technologies to attract industry partners

--Established skills to define unmet needs and assess early-stage ideas for commercializing medical devices in early stage of development

--Research assistant in Dr. Deok-Ho Kim's laboratory--Led an interdisciplinary team consisting of both academia and industry on a research project that resulted in a first-author publication--Spearheaded a research collaboration with another academic lab on a research project that led to publication and provided key data for a start-up company--Developed expertise in stem cell differentiation, tissue engineering, and regenerative medicine

--Research assistant in Dr. G. Graham Allan's laboratory--Performed scientific literature analysis for hydrogen generation from water

--Visiting scholar in Dr. Hai-Quan Mao's laboratory--Developed and optimized a hydrogel platform for delivering a gradient of chemotrophic factors to assess Schwann cell migration--Initiated collaboration project with Dr. Denis Wirtz lab to assess focal adhesion complex formation in Schwann cells